logo

Shariah compliance overview

Halal

Starling Oncology, Inc. (STLN) is currently classified as Halal by Akinda Shariah screening (AAOIFI-aligned methodology).

About Starling Oncology, Inc.

Starling Oncology, Inc., formerly The Oncology Institute, is a value-based oncology company advancing cancer care in the community setting. Founded in 2007, the company offers cutting-edge, evidence-based cancer treatments, including clinical trials and transfusions, to a large patient population.

Starling Oncology, Inc. (STLN) operates in the Healthcare sector, in the Medical - Care Facilities industry.

Why it is halal: it passes all three AAOIFI screens. Non-compliant revenue is 0.00% (limit 5%), interest-bearing debt is 13.22% (limit 30%) and interest-bearing securities and assets are 5.73% (limit 30%).

Business Activity
0.00%Limit 5%Pass
Interest-bearing debt
13.22%Limit 30%Pass
Interest-bearing securities and assets
5.73%Limit 30%Pass
Dividend purification
0.00%Share of dividends to give to charityPurification calculator

Last updated: Nov 3, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.

Please login to access this content

Key stats

Please login to access this content

Please login to access this content

Company Profile

Please login to access this content

Frequently asked questions

Quick answers about Starling Oncology, Inc. (STLN). Current Akinda screening label: Halal.